Cargando…
Antibodies Against Anthrax: Mechanisms of Action and Clinical Applications
B. anthracis is a bioweapon of primary importance and its pathogenicity depends on its lethal and edema toxins, which belong to the A-B model of bacterial toxins, and on its capsule. These toxins are secreted early in the course of the anthrax disease and for this reason antibiotics must be administ...
Autores principales: | Froude, Jeffrey W., Thullier, Philippe, Pelat, Thibaut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237005/ https://www.ncbi.nlm.nih.gov/pubmed/22174979 http://dx.doi.org/10.3390/toxins3111433 |
Ejemplares similares
-
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside
por: Avril, Arnaud, et al.
Publicado: (2022) -
Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail
por: Froude, Jeffrey W., et al.
Publicado: (2018) -
Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor
por: Thullier, Philippe, et al.
Publicado: (2013) -
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
por: Pelat, Thibaut, et al.
Publicado: (2009) -
Structural differences of amyloid-β fibrils revealed by antibodies from phage display
por: Droste, Patrick, et al.
Publicado: (2015)